We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$2.76B
Cap. Flow
-$1.55B
Cap. Flow %
-3.85%
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
649
Reduced
1,111
Closed
232

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$83M
2
MS icon
Morgan Stanley
MS
+$67.7M
3
GPCR icon
Structure Therapeutics
GPCR
+$66.3M
4
ABBV icon
AbbVie
ABBV
+$63.8M
5
KVUE icon
Kenvue
KVUE
+$60.5M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$207M
2
WMB icon
Williams Companies
WMB
+$150M
3
VZ icon
Verizon
VZ
+$128M
4
SPLK
Splunk Inc
SPLK
+$123M
5
CSCO icon
Cisco
CSCO
+$93.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.22%
2 Technology 16.21%
3 Financials 12.58%
4 Industrials 9.73%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAKT icon
1951
Daktronics
DAKT
$860M
$1.31K ﹤0.01%
155
+55
+55% +$525
BBW icon
1952
Build-A-Bear
BBW
$335M
$1.29K ﹤0.01%
+56
New +$1.42K
TRVI icon
1953
Trevi Therapeutics
TRVI
$2.26B
$1.27K ﹤0.01%
+950
New +$1.44K
ZUO
1954
DELISTED
Zuora, Inc.
ZUO
$1.23K ﹤0.01%
131
-29,631
-100% -$245K
CSTE icon
1955
Caesarstone
CSTE
$110M
$1.21K ﹤0.01%
324
-86
-21% -$347
WKHS icon
1956
Workhorse Group
WKHS
$32.9M
$1.2K ﹤0.01%
1
NPCE icon
1957
Neuropace
NPCE
$482M
$1.2K ﹤0.01%
116
-308
-73% -$2.46K
SNCR
1958
DELISTED
Synchronoss Technologies
SNCR
$1.18K ﹤0.01%
190
-340
-64% -$1.66K
ICHR icon
1959
Ichor Holdings
ICHR
$1.92B
$1.18K ﹤0.01%
+35
New +$969
EPM icon
1960
Evolution Petroleum
EPM
$133M
$1.17K ﹤0.01%
+201
New +$1.23K
FBP icon
1961
First Bancorp
FBP
$4.23B
$1.17K ﹤0.01%
71
-2,762
-97% -$40.8K
MACK
1962
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.14K ﹤0.01%
85
-3
-3% -$38
HOV icon
1963
Hovnanian Enterprises
HOV
$700M
$1.09K ﹤0.01%
7
-43
-86% -$4.33K
OKUR
1964
OnKure Therapeutics
OKUR
$126M
$1.03K ﹤0.01%
65
-5,945
-99% -$370K
JAKK icon
1965
Jakks Pacific
JAKK
$277M
$995 ﹤0.01%
+28
New +$724
IBRX icon
1966
ImmunityBio
IBRX
$8.87B
$989 ﹤0.01%
197
-63
-24% -$198
HYLN icon
1967
Hyliion Holdings
HYLN
$677M
$979 ﹤0.01%
+1,203
New +$854
STRO icon
1968
Sutro Biopharma
STRO
$280M
$957 ﹤0.01%
22
-617
-97% -$19.6K
IMNM icon
1969
Immunome
IMNM
$2.8B
$931 ﹤0.01%
+87
New +$723
IMUX icon
1970
Immunic
IMUX
$153M
$921 ﹤0.01%
+61
New +$747
WHWK
1971
Whitehawk Therapeutics
WHWK
$234M
$919 ﹤0.01%
+455
New +$1.91K
XPER icon
1972
Xperi
XPER
$287M
$893 ﹤0.01%
+81
New +$781
WVE icon
1973
Wave Life Sciences
WVE
$902M
$874 ﹤0.01%
173
-141
-45% -$754
VERI icon
1974
Veritone
VERI
$116M
$871 ﹤0.01%
+481
New +$1.07K
CDRE icon
1975
Cadre Holdings
CDRE
$1.22B
$855 ﹤0.01%
+26
New +$786

Similar funds

Federated Hermes's Q4 2023 Portfolio in Review

As of Q4 2023, Federated Hermes held 2,266 positions worth $40.3B, up 7.3% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Federated Hermes withdrew a net $1.55B in Q4 2023, closing 232 positions and reducing 1,111 holdings. Its most notable exit was Splunk Inc, an estimated $123M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Federated Hermes opened a new position in Zscaler worth $39.2M.

  • Federated Hermes's largest Q4 2023 buy was Zscaler: 177,136 shares worth $39.2M.
  • Federated Hermes added most to GoDaddy in Q4 2023, an estimated $83M increase.
  • Federated Hermes's biggest Q4 2023 reduction was Amgen, cutting an estimated $207M.
  • Federated Hermes fully exited Splunk Inc in Q4 2023, selling an estimated $123M.
  • Federated Hermes's ten largest holdings make up 14% of its $40.3B portfolio in Q4 2023.
  • Federated Hermes opened 182 new positions and closed 232 in Q4 2023.
  • Federated Hermes's portfolio value rose 7.3% quarter-over-quarter to $40.3B.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.